Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Knatterud

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Circulation|April 15, 1997
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularizationR F Davies, A D Goldberg, S Forman, et al.
Journal of the American College of Cardiology|December 1, 1995
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarctionH V Anderson, C P Cannon, P H Stone, et al.
Circulation|February 1, 1991
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trialJ M Gore, M Sloan, T R Price, et al.
Journal of the American College of Cardiology|November 1, 1989
The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI InvestigatorsB R Chaitman, B Thompson, M D Wittry, et al.
Atherosclerosis|October 26, 1999
The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trialP Alaupovic, J D Fesmire, D Hunnighake, et al.
The European Respiratory Journal|October 2, 2004
Sarcoidosis: social predictors of severity at presentationD L Rabin, B Thompson, K M Brown, et al.
Journal of the American College of Cardiology|February 1, 1995
Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II)B J Gersh, J H Chesebro, E Braunwald, et al.
Diabetes|May 26, 1999
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft TrialB J Hoogwerf, A Waness, M Cressman, et al.
Circulation|November 1, 1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABGM G Bourassa, G L Knatterud, C J Pepine, et al.
Circulation|February 1, 1991
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B StudyR Roberts, W J Rogers, H S Mueller, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Circulation|April 15, 1997
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularizationR F Davies, A D Goldberg, S Forman, et al.
Journal of the American College of Cardiology|December 1, 1995
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarctionH V Anderson, C P Cannon, P H Stone, et al.
Circulation|February 1, 1991
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trialJ M Gore, M Sloan, T R Price, et al.
Journal of the American College of Cardiology|November 1, 1989
The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI InvestigatorsB R Chaitman, B Thompson, M D Wittry, et al.
Atherosclerosis|October 26, 1999
The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trialP Alaupovic, J D Fesmire, D Hunnighake, et al.
The European Respiratory Journal|October 2, 2004
Sarcoidosis: social predictors of severity at presentationD L Rabin, B Thompson, K M Brown, et al.
Journal of the American College of Cardiology|February 1, 1995
Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II)B J Gersh, J H Chesebro, E Braunwald, et al.
Diabetes|May 26, 1999
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft TrialB J Hoogwerf, A Waness, M Cressman, et al.
Circulation|November 1, 1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABGM G Bourassa, G L Knatterud, C J Pepine, et al.
Circulation|February 1, 1991
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B StudyR Roberts, W J Rogers, H S Mueller, et al.
Pageof 8